Key exclusion criteria included: any clinically significant disease history or systemic or organ disease
Other research suggests the drugs might increase the risk of acute kidney injury (StatPearls) and gastrointestinal disorders (Nature Medicine)
Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR
Media coverage and celebrity interest amplified awareness
Some people may be more sensitive to medications, which could increase their chances of having side effects like leg cramps
Semaglutide Semaglutide is a GLP-1 receptor agonist, a synthetic analog of glucagon-like peptide-1, an intestinal hormone released after eating